Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Lars Ditlev ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.1%   Bankruptcy risk   3.2% 2.4% 3.4% 2.9% 3.3% 3.5% 7.8% 6.6%   Credit score (0-100)   58 65 56 58 53 53 3 3   Credit rating   BBB BBB BBB BBB BBB BBB BB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,037 2,035 955 -99.0 -302 -207 0.0 0.0   EBITDA   418 787 -50.7 -934 -936 -858 0.0 0.0   EBIT   322 622 -209 -1,094 -1,103 -1,241 0.0 0.0   Pre-tax profit (PTP)   239.7 497.1 667.8 337.0 384.1 144.6 0.0 0.0   Net earnings   186.7 387.8 520.8 264.1 291.2 112.7 0.0 0.0   Pre-tax profit without non-rec. items   240 497 668 337 384 145 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Tangible assets total   392 350 694 637 532 2,148 0.0 0.0   Shareholders equity total   237 624 1,092 1,302 1,573 1,629 1,520 1,520   Interest-bearing liabilities   1,278 1,085 0.0 0.0 0.0 1,265 0.0 0.0   Balance sheet total (assets)   2,034 2,679 2,087 2,502 2,597 4,012 1,520 1,520   Net Debt   1,179 324 -70.6 -460 -276 827 -593 -593     See the entire balance sheet 1000.0 Volume  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,037 2,035 955 -99.0 -302 -207 0.0 0.0   Gross profit growth   0.0% 96.3% -53.1% 0.0% -204.5% 31.3% 0.0% 0.0%   Employees   0 0 0 0 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,034 2,679 2,087 2,502 2,597 4,012 1,520 1,520   Balance sheet change%   0.0% 31.7% -22.1% 19.9% 3.8% 54.5% -62.1% 0.0%   Added value   322.2 621.5 -208.6 -1,094.0 -1,103.4 -1,240.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   1,500 -269 154 -274 -335 1,170 -2,148 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   31.1% 30.5% -21.8% 1,104.7% 365.9% 598.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   15.8% 26.4% 31.8% 18.3% 20.4% 8.7% 0.0% 0.0%   ROI %   20.6% 36.5% 48.8% 30.3% 31.5% 11.6% 0.0% 0.0%   ROE %   78.9% 90.1% 60.7% 22.1% 20.3% 7.0% 0.0% 0.0%   1000.0 Solidity  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Equity ratio %   7.6% 23.3% 52.3% 52.0% 60.6% 40.6% 100.0% 50.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   282.3% 41.1% 139.2% 49.3% 29.5% -96.4% 0.0% 0.0%   Gearing %   540.1% 173.8% 0.0% 0.0% 0.0% 77.7% 0.0% -39.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   12.9% 10.6% 16.4% 0.0% 0.0% 22.4% 0.0% 0.0%   1000.0 Liquidity  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Quick Ratio   0.6 1.1 0.3 0.8 1.3 0.4 0.0 0.0   Current Ratio   0.6 1.1 0.3 0.8 1.3 0.4 0.0 0.0   Cash and cash equivalent   99.3 761.5 70.6 460.2 276.3 437.7 0.0 0.0   1000.0 Capital use efficiency  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -259.5 109.4 -547.0 -194.8 267.2 -1,189.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 -1,103 -1,241 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 -936 -858 0 0   EBIT / employee   0 0 0 0 -1,103 -1,241 0 0   Net earnings / employee   0 0 0 0 291 113 0 0